172 related articles for article (PubMed ID: 9068517)
21. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina.
Egashira K; Katsuda Y; Mohri M; Kuga T; Tagawa T; Shimokawa H; Takeshita A
J Am Coll Cardiol; 1996 May; 27(6):1444-9. PubMed ID: 8626956
[TBL] [Abstract][Full Text] [Related]
22. Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectoris.
Tanaka H; Yasue H; Yoshimura M; Morita E; Jougasaki M; Kato H; Miyao Y; Nakao K
Am J Cardiol; 1993 Jul; 72(2):128-33. PubMed ID: 8392283
[TBL] [Abstract][Full Text] [Related]
23. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
Kugiyama K; Yasue H; Ohgushi M; Motoyama T; Kawano H; Inobe Y; Hirashima O; Sugiyama S
J Am Coll Cardiol; 1996 Nov; 28(5):1161-7. PubMed ID: 8890810
[TBL] [Abstract][Full Text] [Related]
24. Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Enomoto T; Yasui K; Sugishita Y
Circulation; 1993 Jul; 88(1):29-36. PubMed ID: 8391401
[TBL] [Abstract][Full Text] [Related]
25. Myocardial bridging increases the risk of coronary spasm.
Teragawa H; Fukuda Y; Matsuda K; Hirao H; Higashi Y; Yamagata T; Oshima T; Matsuura H; Chayama K
Clin Cardiol; 2003 Aug; 26(8):377-83. PubMed ID: 12918640
[TBL] [Abstract][Full Text] [Related]
26. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina.
Kugiyama K; Motoyama T; Hirashima O; Ohgushi M; Soejima H; Misumi K; Kawano H; Miyao Y; Yoshimura M; Ogawa H; Matsumura T; Sugiyama S; Yasue H
J Am Coll Cardiol; 1998 Jul; 32(1):103-9. PubMed ID: 9669256
[TBL] [Abstract][Full Text] [Related]
27. Nitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1).
Drobinski G; Montalescot G
Eur Heart J; 1990 May; 11(5):472-5. PubMed ID: 2112998
[TBL] [Abstract][Full Text] [Related]
28. Administration of the Rho-kinase inhibitor, fasudil, following nitroglycerin additionally dilates the site of coronary spasm in patients with vasospastic angina.
Otsuka T; Ibuki C; Suzuki T; Ishii K; Yoshida H; Kodani E; Kusama Y; Atarashi H; Kishida H; Takano T; Mizuno K
Coron Artery Dis; 2008 Mar; 19(2):105-10. PubMed ID: 18300747
[TBL] [Abstract][Full Text] [Related]
29. Nitroglycerin is superior to diltiazem as a coronary bypass conduit vasodilator.
Shapira OM; Xu A; Vita JA; Aldea GS; Shah N; Shemin RJ; Keaney JF
J Thorac Cardiovasc Surg; 1999 May; 117(5):906-11. PubMed ID: 10220683
[TBL] [Abstract][Full Text] [Related]
30. Surgery for left main spasm. Is it indicated?
Ng WL; Sim EK; Yeo TC; Lim YT
Int J Cardiol; 1996 Jun; 54(3):213-6. PubMed ID: 8818743
[No Abstract] [Full Text] [Related]
31. Persistence of recruitable coronary collaterals in the absence of coronary vasospasm in a patient with variant angina.
Yamashita K; Takeuchi M; Nakashima Y
Cardiovasc Intervent Radiol; 1998; 21(3):249-51. PubMed ID: 9626445
[TBL] [Abstract][Full Text] [Related]
32. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure.
Matsumoto T; Wada A; Tsutamoto T; Omura T; Yokohama H; Ohnishi M; Nakae I; Takahashi M; Kinoshita M
Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673
[TBL] [Abstract][Full Text] [Related]
33. Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina.
Kugiyama K; Miyao Y; Sakamoto T; Kawano H; Soejima H; Miyamoto S; Yoshimura M; Ogawa H; Sugiyama S; Yasue H
Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H264-71. PubMed ID: 11123241
[TBL] [Abstract][Full Text] [Related]
34. Two possible mechanisms underlying nitrate tolerance in monkey coronary arteries.
Omura T; Matsumoto T; Nakae I; Takahashi M; Kinoshita M
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):259-65. PubMed ID: 11251637
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous and diffuse coronary artery spasm unresponsive to conventional intracoronary pharmacological therapy: a case report.
Rashid H; Marshall RJ; Diver DJ; Breall JA
Catheter Cardiovasc Interv; 2000 Feb; 49(2):188-91. PubMed ID: 10642771
[No Abstract] [Full Text] [Related]
36. Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation.
Malyshev Y; Neuzil P; Petru J; Funasako M; Hala P; Kopriva K; Schneider C; Achyutha A; Vanderper A; Musikantow D; Turagam M; Dukkipati SR; Reddy VY
JACC Clin Electrophysiol; 2024 May; 10(5):885-896. PubMed ID: 38385916
[TBL] [Abstract][Full Text] [Related]
37. [Pathophysiology of coronary spasm].
Kugiyama K; Yasue H
Nihon Rinsho; 1998 Oct; 56(10):2483-7. PubMed ID: 9796306
[TBL] [Abstract][Full Text] [Related]
38. Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs.
Stewart DJ; Holtz J; Bassenge E
Circulation; 1987 Apr; 75(4):847-56. PubMed ID: 2881635
[TBL] [Abstract][Full Text] [Related]
39. Vasodilatory effect of subsequent administration of fasudil, a rho-kinase inhibitor, surpasses that of nitroglycerin at the concentric coronary stenosis in patients with stable angina pectoris.
Otsuka T; Ibuki C; Suzuki T; Ishii K; Kodani E; Atarashi H; Kishida H; Takano T
Circ J; 2006 Apr; 70(4):402-8. PubMed ID: 16565555
[TBL] [Abstract][Full Text] [Related]
40. Clinical effects and utility of intracoronary diltiazem.
McIvor ME; Undemir C; Lawson J; Reddinger J
Cathet Cardiovasc Diagn; 1995 Aug; 35(4):287-91, discussion 92-3. PubMed ID: 7497500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
